NXPI vs TELO · P/E 29, rev $12.27B vs $86.0M cap
NXP Semiconductors NV (NXPI) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
TELO does not have a complete income-statement cache yet.
NXPI currently screens at market cap $76.47B and trailing P/E 29.0. TELO currently screens at market cap $86.0M.
Not investment advice. Open the NXPI and TELO stock pages for the full models.
Not investment advice.